ACHE and Alzheimer disease: Finally, recent studies have shown that APAP shows nootropic activity through increasing the escape latency in the step through passive avoidance paradigm task and decreasing acetyl cholinesterase activity in colchicine-induced cognitive impairment (an animal model for AD) in rats [29], suggesting a possible therapeutic effect of APAP in AD.